Home

Intercure Ltd. - ordinary shares (INCR)

1.7400
+0.1300 (8.07%)

Intercure Ltd is a prominent player in the global cannabis industry, focusing on the cultivation, production, and distribution of medical cannabis products

The company is dedicated to providing high-quality cannabis solutions for patients, emphasizing the therapeutic benefits of its offerings. With a commitment to innovation and research, Intercure aims to expand its market presence and improve the accessibility of medical cannabis, while also adhering to stringent regulatory standards. Through strategic partnerships and a diverse product portfolio, the company seeks to position itself as a leader in the ever-evolving cannabis market.

SummaryNewsPress ReleasesChartHistoricalFAQ
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Companybenzinga.com
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.
Via Benzinga · September 14, 2024
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germanybenzinga.com
Via Benzinga · August 30, 2024
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizonbenzinga.com
Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s recent decriminalization have ignited optimism within the sector.
Via Benzinga · July 18, 2024
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQbenzinga.com
The potential rescheduling of cannabis in the U.S.
Via Benzinga · May 24, 2024
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansionbenzinga.com
"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.
Via Benzinga · May 2, 2024
5 Value Stocks In The Healthcare Sectorbenzinga.com
Via Benzinga · May 8, 2023
Overview Of Value Stocks In The Healthcare Sectorbenzinga.com
Via Benzinga · April 17, 2023
This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflictbenzinga.com
Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.
Via Benzinga · April 1, 2024
Canndoc Reports Record Revenue Amid Cannabis Market Turmoilbenzinga.com
InterCure Ltd. (NASDAQINCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023,
Via Benzinga · September 1, 2023
Cannabis Stock Gainers And Losers From August 24, 2023benzinga.com
Via Benzinga · August 24, 2023
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023benzinga.com
Via Benzinga · August 21, 2023
Cannabis Stock Movers For August 18, 2023benzinga.com
Via Benzinga · August 18, 2023
Cannabis Stock Gainers And Losers From August 14, 2023benzinga.com
Via Benzinga · August 14, 2023
Stocks That Hit 52-Week Lows On Wednesdaybenzinga.com
  Wednesday's session saw 43 companies set new 52-week lows.
Via Benzinga · July 5, 2023
Cannabis Stock Movers For August 10, 2023benzinga.com
Via Benzinga · August 10, 2023
Medical Cannabis Company Better Is Suing InterCure For $35Mbenzinga.com
Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQINCR) for $35 million.
Via Benzinga · June 15, 2023
InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Detailsbenzinga.com
InterCure Ltd. (NASDAQINCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million) representing 22% growth YoY and up 1% sequenti
Via Benzinga · May 16, 2023
Marijuana Stock Movers For August 9, 2023benzinga.com
Via Benzinga · August 9, 2023
Why Are Cannabis Stocks Trading Higher Today?benzinga.com
Cannabis stocks shot up in Thursday's pre-market and are holding.
Via Benzinga · April 27, 2023
Marijuana Stock Movers For August 8, 2023benzinga.com
Via Benzinga · August 8, 2023
InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countriesbenzinga.com
InterCure Ltd. (NASDAQINCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership.
Via Benzinga · April 20, 2023
Cannabis Stock Movers For July 24, 2023benzinga.com
Via Benzinga · July 24, 2023
Nasdaq Down 80 Points; VirTra Shares Spike Higherbenzinga.com
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P 500, also rose, gaining, 0.17% to 4,116.15.
Via Benzinga · April 3, 2023
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers Nogin, Inc. (NASDAQNOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited NASDAQ: GFAINASDAQGFAI)
Via Benzinga · April 3, 2023
Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummetbenzinga.com
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The S&P 500, also fell, dropping, 0.10% to 4,105.19.
Via Benzinga · April 3, 2023